Inscrição na biblioteca: Guest
Critical Reviews™ in Therapeutic Drug Carrier Systems

Publicou 6 edições por ano

ISSN Imprimir: 0743-4863

ISSN On-line: 2162-660X

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 2.7 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 3.6 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.8 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00023 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.39 SJR: 0.42 SNIP: 0.89 CiteScore™:: 5.5 H-Index: 79

Indexed in

In Vivo Delivery Aspects of miRNA, shRNA and siRNA

Volume 29, Edição 6, 2012, pp. 487-527
DOI: 10.1615/CritRevTherDrugCarrierSyst.v29.i6.20
Get accessGet access

RESUMO

RNA interference (RNAi) is a wondrous phenomenon that silences the expression of targeted genes via distinct messenger RNA degradation pathways. It has the potential as a therapeutic agent for variety of diseases, including viral infections, cancer, and immune diseases. RNAi mainly conducts gene regulation by 3 ways: microRNA, short hairpin RNA, and small interfering RNA. However, in vivo delivery of RNAi therapeutics is restricted because of charge density, molecular weight, and instability in the presence of nucleases. Furthermore, intracellular accumulation and endosomal escape have remained significant barriers in the delivery of these macromolecules. Many viral and nonviral delivery vectors have been thoroughly investigated to overcome these barriers. Researchers have found applications for RNAi in a variety of diseases and, hence, various delivery systems have been explored to satisfy the need. Both local and systemic strategies have been utilized to elicit RNAi's effect and each carries its own therapeutic implications with varying margins of safety. This review is an effort to describe the types of RNAi and their application in a variety of diseases using both local and systemic delivery approaches. It is sure that advancement in this direction will evolve a new landscape for treating a range of diseases.

CITADO POR
  1. Vauthier Christine, Zandanel Christelle, Ramon Anne Laure, Chitosan-based nanoparticles for in vivo delivery of interfering agents including siRNA, Current Opinion in Colloid & Interface Science, 18, 5, 2013. Crossref

  2. Zhang Yu, Wang Zaijie, Gemeinhart Richard A., Progress in microRNA delivery, Journal of Controlled Release, 172, 3, 2013. Crossref

  3. Kuang Yuyang, An Sai, Guo Yubo, Huang Shixian, Shao Kun, Liu Yang, Li Jianfeng, Ma Haojun, Jiang Chen, T7 peptide-functionalized nanoparticles utilizing RNA interference for glioma dual targeting, International Journal of Pharmaceutics, 454, 1, 2013. Crossref

  4. Yang Dakai, Möbus Selina, Balakrishnan Asha, Sharma Amar Deep, MicroRNAs in Liver Regeneration, in MicroRNA in Regenerative Medicine, 2015. Crossref

  5. Khatri Nirav, Baradia Dipesh, Vhora Imran, Rathi Mohan, Misra Ambikanandan, Development and Characterization of siRNA Lipoplexes: Effect of Different Lipids, In Vitro Evaluation in Cancerous Cell Lines and In Vivo Toxicity Study, AAPS PharmSciTech, 15, 6, 2014. Crossref

  6. Khatri Nirav, Baradia Dipesh, Vhora Imran, Rathi Mohan, Misra Ambikanandan, cRGD grafted liposomes containing inorganic nano-precipitate complexed siRNA for intracellular delivery in cancer cells, Journal of Controlled Release, 182, 2014. Crossref

  7. Zaporozhan V. M., Maryniuk G. S., Kholodkova O. L., Bubnov V. V., Andronov D. U., Impact of siRNA transfection on tumor development under experimental pathology of thyroid gland, Biopolymers and Cell, 29, 6, 2013. Crossref

  8. Wang Jing, Chen Dengyu, He Xiangfeng, Zhang Yuxia, Shi Fangfang, Wu Di, Chen Junsong, Zhang Ying, Zhao Fengsu, Dou Jun, Downregulated lincRNA HOTAIR expression in ovarian cancer stem cells decreases its tumorgeniesis and metastasis by inhibiting epithelial-mesenchymal transition, Cancer Cell International, 15, 1, 2015. Crossref

  9. Cao Liangxian, Weetall Marla, Bombard Jenelle, Qi Hongyan, Arasu Tamil, Lennox William, Hedrick Jean, Sheedy Josephine, Risher Nicole, Brooks Peter C., Trifillis Panayiota, Trotta Christopher, Moon Young-Choon, Babiak John, Almstead Neil G., Colacino Joseph M., Davis Thomas W., Peltz Stuart W., Preiss Thomas, Discovery of Novel Small Molecule Inhibitors of VEGF Expression in Tumor Cells Using a Cell-Based High Throughput Screening Platform, PLOS ONE, 11, 12, 2016. Crossref

  10. Qiu Yingshan, Lam Jenny, Leung Susan, Liang Wanling, Delivery of RNAi Therapeutics to the Airways—From Bench to Bedside, Molecules, 21, 9, 2016. Crossref

  11. WANG XIAOXIA, JIANG WENYAN, KANG JIALI, LIU QICAI, NIE MIAOLING, Knockdown of RhoA expression alters ovarian cancer biological behavior in vitro and in nude mice, Oncology Reports, 34, 2, 2015. Crossref

  12. Qin Chu-qiang, Huang Dong-sheng, Zhang Chi, Song Bin, Huang Jian-bin, Ding Yue, Lentivirus-mediated short hairpin RNA interference targeting TNF-alpha in macrophages inhibits particle-induced inflammation and osteolysis in vitro and in vivo, BMC Musculoskeletal Disorders, 17, 1, 2016. Crossref

  13. Campani Virginia, Salzano Giuseppina, Lusa Sara, De Rosa Giuseppe, Lipid Nanovectors to Deliver RNA Oligonucleotides in Cancer, Nanomaterials, 6, 7, 2016. Crossref

  14. Shatsberg Zohar, Zhang Xuejiao, Ofek Paula, Malhotra Shashwat, Krivitsky Adva, Scomparin Anna, Tiram Galia, Calderón Marcelo, Haag Rainer, Satchi-Fainaro Ronit, Functionalized nanogels carrying an anticancer microRNA for glioblastoma therapy, Journal of Controlled Release, 239, 2016. Crossref

  15. Kaur Indu Pal, Sharma Gaurav, Singh Mandeep, Sandhu Simarjot Kaur, Deol Parneet K., Yadav Monika, Yakhmi Jatinder Vir, Nanobiomaterials as gene-delivery vehicles, in Nanobiomaterials in Drug Delivery, 2016. Crossref

  16. Lin Ivan, Van Thi, Smooker Peter, Live-Attenuated Bacterial Vectors: Tools for Vaccine and Therapeutic Agent Delivery, Vaccines, 3, 4, 2015. Crossref

  17. Jin Feng, Han Guang-Kui, Zhang Hao, Zhang Ran, Li Gen-Hua, Feng Song, Qin Xian-Yun, Kong Ling-Sheng, Nie Quan-Min, Li Hua-Rong, Zhao Lei, Difference in the Inhibitory Effect of Temozolomide on TJ905 Glioma Cells and Stem Cells, Frontiers in Neurology, 8, 2017. Crossref

  18. Dewanjee Saikat, Bhattacharjee Niloy, MicroRNA: A new generation therapeutic target in diabetic nephropathy, Biochemical Pharmacology, 155, 2018. Crossref

  19. Nagesh Prashanth, Chowdhury Pallabita, Hatami Elham, Boya Vijaya, Kashyap Vivek, Khan Sheema, Hafeez Bilal, Chauhan Subhash, Jaggi Meena, Yallapu Murali, miRNA-205 Nanoformulation Sensitizes Prostate Cancer Cells to Chemotherapy, Cancers, 10, 9, 2018. Crossref

  20. Arora Mansi, Kaul Deepak, RNome in Cancer Therapy, in Cancer RNome: Nature & Evolution, 2018. Crossref

  21. Yalcin Serap, Gündüz Ufuk, Iron Oxide-Based Polymeric Magnetic Nanoparticles for Drug and Gene Delivery: In Vitro and In Vivo Applications in Cancer, in Handbook of Polymer and Ceramic Nanotechnology, 2019. Crossref

  22. Bai Zhiman, Wei Jing, Yu Changmin, Han Xisi, Qin Xiaofei, Zhang Chengwu, Liao Wenzhen, Li Lin, Huang Wei, Non-viral nanocarriers for intracellular delivery of microRNA therapeutics, Journal of Materials Chemistry B, 7, 8, 2019. Crossref

  23. Fernandez-Moure Joseph S., Van Eps Jeffrey, Weiner Bradley K., Ferrari Mauro, Tasciotti Ennio, MicroRNA and Drug Delivery, in MicroRNA in Development and in the Progression of Cancer, 2014. Crossref

  24. Llewellyn George Nicholas, Exline Colin M., Holt Nathalia, Cannon Paula M., Using Engineered Nucleases to Create HIV-Resistant Cells, in Genome Editing, 2016. Crossref

  25. Conroy Richard, Seto Belinda, Multifunctional Nanoscale Delivery Systems for Nucleic Acids, in Engineering in Translational Medicine, 2014. Crossref

  26. Nasuha Aznan Afiah, Jubri Zakiah, Silencing of Peroxiredoxin-4 in Anticancer Activity of Gamma-Tocotrienol, in Synthetic Biology - New Interdisciplinary Science, 2020. Crossref

  27. Mroweh Mariam, Decaens Thomas, Marche Patrice N, Macek Jilkova Zuzana, Clément Flora, Modulating the Crosstalk between the Tumor and Its Microenvironment Using RNA Interference: A Treatment Strategy for Hepatocellular Carcinoma, International Journal of Molecular Sciences, 21, 15, 2020. Crossref

  28. Wu Xueliang, Yan Fuguo, Wang Likun, Sun Guangyuan, Liu Jinyu, Qu Ming, Wang Yicheng, Li Tian, MicroRNA: Another Pharmacological Avenue for Colorectal Cancer?, Frontiers in Cell and Developmental Biology, 8, 2020. Crossref

  29. Liboiron Barry D, Mayer Lawrence D, Nanoscale particulate systems for multidrug delivery: towards improved combination chemotherapy, Therapeutic Delivery, 5, 2, 2014. Crossref

  30. Gandhi Gayatri, Abdullah Syahril, Foead Agus Iwan, Yeo Wendy Wai Yeng, The potential role of miRNA therapies in spinal muscle atrophy, Journal of the Neurological Sciences, 427, 2021. Crossref

  31. Patel Vivek, Lalani Rohan, Vhora Imran, Bardoliwala Denish, Patel Akanksha, Ghosh Saikat, Misra Ambikanandan, Co-delivery of cisplatin and siRNA through hybrid nanocarrier platform for masking resistance to chemotherapy in lung cancer, Drug Delivery and Translational Research, 11, 5, 2021. Crossref

  32. Patel Vivek, Bardoliwala Denish, Lalani Rohan, Patil Sushilkumar, Ghosh Saikat, Javia Ankit, Misra Ambikanandan, Development of a dry powder for inhalation of nanoparticles codelivering cisplatin and ABCC3 siRNA in lung cancer, Therapeutic Delivery, 12, 9, 2021. Crossref

  33. Yalcin Serap, Gündüz Ufuk, Iron Oxide-Based Polymeric Magnetic Nanoparticles for Drug and Gene Delivery: In Vitro and In Vivo Applications in Cancer, in Handbook of Polymer and Ceramic Nanotechnology, 2021. Crossref

  34. Chernikov I. V., Meschaninova M. I., Gladkikh D. V., Ven’yaminova A. G., Zenkova M. A., Vlassov V. V., Chernolovskaya E. L., Interaction of Lipophilic Conjugates of Modified siRNAs with Hematopoietic Cells In Vitro and In Vivo, Russian Journal of Bioorganic Chemistry, 47, 2, 2021. Crossref

  35. Mocanu Cristina Ana, Fuior Elena Valeria, Voicu Geanina, Rebleanu Daniela, Safciuc Florentina, Deleanu Mariana, Fenyo Ioana Madalina, Escriou Virginie, Manduteanu Ileana, Simionescu Maya, Calin Manuela, P-selectin targeted RAGE-shRNA lipoplexes alleviate atherosclerosis-associated inflammation, Journal of Controlled Release, 338, 2021. Crossref

  36. Cao Guangxu, Li Shuang, Shi Hezhan, Yin Peidi, Chen Jialing, Li Huifeng, Zhong Ying, Diao Li-Ting, Du Bin, Schisandrin B attenuates renal fibrosis via miR-30e-mediated inhibition of EMT, Toxicology and Applied Pharmacology, 385, 2019. Crossref

  37. Rahbarnia Leila, Farajnia Safar, Naghili Behrooz, Ahmadzadeh Vahideh, Veisi Kamal, Baghban Roghayyeh, Toraby Sayna, Current trends in targeted therapy for drug-resistant infections, Applied Microbiology and Biotechnology, 103, 20, 2019. Crossref

  38. Gasparello Jessica, Lomazzi Michela, Papi Chiara, D’Aversa Elisabetta, Sansone Francesco, Casnati Alessandro, Donofrio Gaetano, Gambari Roberto, Finotti Alessia, Efficient Delivery of MicroRNA and AntimiRNA Molecules Using an Argininocalix[4]arene Macrocycle, Molecular Therapy - Nucleic Acids, 18, 2019. Crossref

  39. Teng Xin-Qi, Qu Jian, Li Guo-Hua, Zhuang Hai-Hui, Qu Qiang, Small Interfering RNA for Gliomas Treatment: Overcoming Hurdles in Delivery, Frontiers in Cell and Developmental Biology, 10, 2022. Crossref

Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa Políticas de preços e assinaturas Begell House Contato Language English 中文 Русский Português German French Spain